AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23455863 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional adhesive tape)
Number of subjects: 50
Study 21801537 — intervention group
Group type: EXPERIMENTAL
Intervention: The Hip & Knee Book
Number of subjects: 119
Study 21801537 — intervention group
Group type: COMPARATOR
Intervention: Control booklet
Number of subjects: 119
Study 19397673 — intervention group
Group type: EXPERIMENTAL
Intervention: Deoxycholate
Number of subjects: 42
Study 19397673 — intervention group
Group type: COMPARATOR
Intervention: Phosphatidylcholine/deoxycholate
Number of subjects: 42
Study 16466599 — intervention group
Group type: EXPERIMENTAL
Intervention: Inert cellulose powder
Number of subjects: 97
Study 16466599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 15131556 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 49)
Number of subjects: 88
Study 15131556 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 39)
Number of subjects: 88
Study 11677548 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 75
Study 11677548 — intervention group
Group type: EXPERIMENTAL
Intervention: McGill Pain Questionnaire
Number of subjects: 75
Study 9222726 — intervention group
Group type: EXPERIMENTAL
Intervention: Undetectable total IgA (< 0.07 g/l) as a selection criterion for small bowel biopsy
Number of subjects: 318
Study 9222726 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IgA levels in patients with AGA 0-10 ELISA units (EU)
Number of subjects: 318
Study 9222726 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of median IgA levels
Number of subjects: 318
Study 9222726 — intervention group
Group type: COMPARATOR
Intervention: Controls with AGA 0-10 EU
Number of subjects: 318
Study 8228209 — intervention group
Group type: EXPERIMENTAL
Intervention: lacto-ovovegetarian diet
Number of subjects: 20
Study 8228209 — intervention group
Group type: COMPARATOR
Intervention: omnivorous diet
Number of subjects: 20
Study 3630597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural administration of bupivacaine-adrenaline solution (10 or 20 ml of 2.5 mg/ml or 5 mg/ml)
Number of subjects: 21
Study 3630597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural administration of bupivacaine-adrenaline solution
Number of subjects: 21
Study 3630597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl) given intrapleurally
Number of subjects: 21
Study 31366415 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC)
Number of subjects: 105
Study 31366415 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (10-session home-visiting intervention)
Number of subjects: 105
Study 29020861 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose psilocybin (20 mg/70 kg and 30 mg/70 kg) with standard support (HD-SS)
Number of subjects: 75
Study 29020861 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose psilocybin (20 mg/70 kg and 30 mg/70 kg) with high support (HD-HS)
Number of subjects: 75
Study 29020861 — intervention group
Group type: COMPARATOR
Intervention: Very low-dose psilocybin (1 mg/70 kg) with standard support (LD-SS)
Number of subjects: 75
Study 26928904 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-equol group (10 mg/d)
Number of subjects: 207
Study 26928904 — intervention group
Group type: EXPERIMENTAL
Intervention: High-equol group (20 mg/d)
Number of subjects: 207
Study 26928904 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 207
Study 25229781 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 21
Study 25229781 — intervention group
Group type: COMPARATOR
Intervention: Intense pulsed light (IPL)
Number of subjects: 21
Study 22744655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematoma growth (absolute increase of 10.7 mL over 24 hours)
Number of subjects: 335
Study 22744655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematoma growth (relative growth)
Number of subjects: 335
Study 22744655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematoma growth (1 mL increase)
Number of subjects: 335
Study 19258442 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer advisers (PADs) providing one-to-one psychosocial support and advice on self-management.
Number of subjects: 0
Study 19258442 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer advisers (PADs) as teachers on self-management to their peers with diabetes.
Number of subjects: 0
Study 19258442 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer advisers (PADs) as committee members and advocates for diabetes.
Number of subjects: 0
Study 18165091 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag/balloon technology (ClearScan, ESI)
Number of subjects: 20
Study 18165091 — intervention group
Group type: COMPARATOR
Intervention: Open‐shell technique
Number of subjects: 20
Study 16173531 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation on GB34
Number of subjects: 10
Study 16173531 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study 12528106 — intervention group
Group type: COMPARATOR
Intervention: Brachial artery flow‐mediated dilatation (FMD)
Number of subjects: 25
Study 12528106 — intervention group
Group type: COMPARATOR
Intervention: Pulse wave analysis (PWA) - large artery compliance (C1)
Number of subjects: 25
Study 12528106 — intervention group
Group type: COMPARATOR
Intervention: Pulse wave analysis (PWA) - small artery compliance (C2)
Number of subjects: 25
Study 12528106 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sharp scores
Number of subjects: 25
Study 10373769 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure target < or = 90 mmHg
Number of subjects: 19000
Study 10373769 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure target < or = 85 mmHg
Number of subjects: 19000
Study 10373769 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure target < or = 80 mmHg
Number of subjects: 19000
Study 10373769 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid
Number of subjects: 19000
Study 10373769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19000
Study 8694040 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinduction synthetic hygroscopic dilators (n = 112)
Number of subjects: 240
Study 8694040 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment (control group, n = 128)
Number of subjects: 240
Study 1768542 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural bupivacaine (n = 9)
Number of subjects: 17
Study 1768542 — intervention group
Group type: COMPARATOR
Intervention: Routine anaesthetic and surgical care (Control, n = 8)
Number of subjects: 17
Study 7149895 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo exposure
Number of subjects: 0
Study 7149895 — intervention group
Group type: EXPERIMENTAL
Intervention: Response prevention
Number of subjects: 0
Study 7149895 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal exposure
Number of subjects: 0
Study 7149895 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of all three procedures
Number of subjects: 0
Study 31738927 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 19
Study 31738927 — intervention group
Group type: COMPARATOR
Intervention: Sham (without NIV)
Number of subjects: 19
Study 31738927 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 19
Study 31025199 — intervention group
Group type: EXPERIMENTAL
Intervention: Interoceptive sensitivity (IS) in young adults
Number of subjects: 97
Study 31025199 — intervention group
Group type: EXPERIMENTAL
Intervention: Interoceptive sensitivity (IS) in older adults
Number of subjects: 97
Study 31025199 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological reactivity measures (electrodermal activity, heart rate, heart rate variability) during image viewing
Number of subjects: 97
Study 31025199 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective emotional responses to affect-inducing images
Number of subjects: 97
Study 27845562 — intervention group
Group type: COMPARATOR
Intervention: Brushing with water only
Number of subjects: 60
Study 27845562 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing followed by soaking in Retainer Brite®
Number of subjects: 60
Study 27845562 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing followed by soaking in Kukis®
Number of subjects: 60
Study 27845562 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing followed by soaking in Corega®
Number of subjects: 60
Study 25342290 — intervention group
Group type: EXPERIMENTAL
Intervention: Modufolin® (60 mg/m²)
Number of subjects: 32
Study 25342290 — intervention group
Group type: EXPERIMENTAL
Intervention: Modufolin® (200 mg/m²)
Number of subjects: 32
Study 25342290 — intervention group
Group type: COMPARATOR
Intervention: Isovorin® (60 mg/m²)
Number of subjects: 32
Study 25342290 — intervention group
Group type: COMPARATOR
Intervention: Isovorin® (200 mg/m²)
Number of subjects: 32
Study 24912842 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 236
Study 24912842 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel-releasing intrauterine system
Number of subjects: 236
Study 22640677 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment (treated group)
Number of subjects: 200
Study 22640677 — intervention group
Group type: COMPARATOR
Intervention: Nontreated group (control)
Number of subjects: 200
Study 19242392 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine 1:100,000, surgery initiated 5 minutes after anesthesia
Number of subjects: 200
Study 19242392 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine 1:100,000, surgery initiated 10 minutes after anesthesia
Number of subjects: 200
Study 19242392 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine 1:200,000, surgery initiated 5 minutes after anesthesia
Number of subjects: 200
Study 19242392 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine 1:200,000, surgery initiated 10 minutes after anesthesia
Number of subjects: 200
Study 16463043 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component physical conditioning programme (supervised resistance, aerobic, and balance exercises twice per week, plus home-based exercises once per week)
Number of subjects: 38
Study 16463043 — intervention group
Group type: COMPARATOR
Intervention: Normal daily activities (Control group)
Number of subjects: 38
Study 16463043 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component physical conditioning programme
Number of subjects: 38
Study 15243747 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming economy factors (body length, body mass, propelling size, arm length, distance between center of mass and center of volume, body angle)
Number of subjects: 23
Study 15243747 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized cost of swimming (CS(1.0) x BL(‐1))
Number of subjects: 23
Study 15243747 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of factors (BL, body mass, active drag factor, passive torque, drag efficiency, hydrostatic lift)
Number of subjects: 23
Study 15243747 — intervention group
Group type: EXPERIMENTAL
Intervention: Size-independent factors (torque, floating abilities, swimming technique, active drag)
Number of subjects: 23
Study 15530594 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral interventions to prevent STIs or UPs
Number of subjects: 2157
Study 15530594 — intervention group
Group type: COMPARATOR
Intervention: Control group (prevent physical training injuries and cancer)
Number of subjects: 2157
Study 15530594 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2157
Study 10589537 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta1b
Number of subjects: 718
Study 10589537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 718
Study 8736219 — intervention group
Group type: EXPERIMENTAL
Intervention: Perisaccadic visual localization with brief (250 microseconds), bright (6000 cd/m2), binocular, gaze-point probe flashes.
Number of subjects: 0
Study 8736219 — intervention group
Group type: EXPERIMENTAL
Intervention: Probes presented monocularly at gaze, 6 deg left of gaze, and 6 deg right of gaze during saccades larger than 8 deg.
Number of subjects: 0
Study 8736219 — intervention group
Group type: COMPARATOR
Intervention: Control trials with non-perisaccadic probes and feedback of pointing errors.
Number of subjects: 0
Study 8736219 — intervention group
Group type: EXPERIMENTAL
Intervention: Probes presented within 4 msec of the beginning of saccades.
Number of subjects: 0
Study 8736219 — intervention group
Group type: EXPERIMENTAL
Intervention: Probes presented during and after saccades.
Number of subjects: 0
Study 8736219 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-saccadic localization.
Number of subjects: 0
Study 1646127 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive lobular carcinomas
Number of subjects: 171
Study 1646127 — intervention group
Group type: COMPARATOR
Intervention: Non-lobular invasive carcinomas
Number of subjects: 171
Study 6751132 — intervention group
Group type: EXPERIMENTAL
Intervention: mSAAST
Number of subjects: 625
Study 31087075 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolbetuximab-chemotherapy combination
Number of subjects: 263
Study 29469654 — intervention group
Group type: EXPERIMENTAL
Intervention: Corinthian currant
Number of subjects: 11
Study 26691396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0
Study 26691396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 0
Study 26691396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg and 0.75 mg
Number of subjects: 0
Study 24356596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy (INT)
Number of subjects: 1441
Study 24356596 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CON)
Number of subjects: 1441
Study 22002829 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement group (supporting clients directly)
Number of subjects: 2
Study 22002829 — intervention group
Group type: COMPARATOR
Intervention: Backup group (supporting family members)
Number of subjects: 2
Study 19834333 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 50
Study 19834333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17602076 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored mailed print materials promoting fruit and vegetable consumption, reducing total/saturated fat intake, and increasing exercise for 10 months
Number of subjects: 543
Study 17602076 — intervention group
Group type: COMPARATOR
Intervention: Nontailored mailed materials on diet and exercise available in the public domain for 10 months
Number of subjects: 543
Study 15484202 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based moderate-intensity walking exercise program
Number of subjects: 119
Study 15484202 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 119
Study 11876713 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication treatment
Number of subjects: 686
Study 11876713 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 686
Study 10225539 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 25% metronidazole gel
Number of subjects: 56
Study 10225539 — intervention group
Group type: COMPARATOR
Intervention: Systemic antibiotics (amoxicillin plus clavulanic acid 1 g/day for 14 days)
Number of subjects: 56
Study 7602352 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Number of subjects: 230
Study 30182815 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon
Number of subjects: 39
Study 30182815 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 39
Study 29763951 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D‐CTA TACE
Number of subjects: 29
Study 29763951 — intervention group
Group type: COMPARATOR
Intervention: Traditional TACE
Number of subjects: 29
Study 27191794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-acting insulin (IMI)
Number of subjects: 26
Study 27191794 — intervention group
Group type: COMPARATOR
Intervention: Sliding-scale insulin (SSI)
Number of subjects: 26
Study 25766081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) for 4 weeks
Number of subjects: 64
Study 22996139 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention
Number of subjects: 53
Study 22996139 — intervention group
Group type: COMPARATOR
Intervention: Education-only arm
Number of subjects: 53
Study 22996139 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 53
Study 19105058 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based prevention program (Student Body)
Number of subjects: 167
Study 17766603 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid buffering gel plus diaphragm
Number of subjects: 921
Study 17766603 — intervention group
Group type: COMPARATOR
Intervention: Nonoxynol-9 spermicide plus diaphragm
Number of subjects: 921
Study 15045133 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of unfractionated heparin by low-molecular-weight heparins for regular anticoagulation
Number of subjects: 12
Study 15045133 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigen assays for confirmation of HIT
Number of subjects: 12
Study 15045133 — intervention group
Group type: COMPARATOR
Intervention: Cut-off established in adults for antigen assays
Number of subjects: 12
Study 11573534 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple small boluses of thiopental
Number of subjects: 60
Study 11573534 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bolus of thiopental
Number of subjects: 60
Study 11573534 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of thiopental
Number of subjects: 60
Study 11573534 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 60
Study 9778007 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol alone
Number of subjects: 0
Study 9778007 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and Propofol combination
Number of subjects: 0
Study 9778007 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 9778007 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 0
Study 7785193 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal irradiation
Number of subjects: 15
Study 7785193 — intervention group
Group type: COMPARATOR
Intervention: Polychemotherapy
Number of subjects: 15
Study 3198983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminozolamide suspension
Number of subjects: 11
Study 3198983 — intervention group
Group type: COMPARATOR
Intervention: Aminozolamide gel formulation
Number of subjects: 11
Study 31815582 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX (platinum-based therapy with fluorouracil, leucovorin, and oxaliplatin)
Number of subjects: 202
Study 31815582 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX (in patients with ERCC1 levels < 1.7)
Number of subjects: 202
Study 31815582 — intervention group
Group type: COMPARATOR
Intervention: IT (non‐platinum‐containing regimen of irinotecan and docetaxel)
Number of subjects: 202
Study 31815582 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX
Number of subjects: 202
Study 29112801 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine Assessment of Patient Index Data 3 (RAPID3)
Number of subjects: 0
Study 28618297 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained group (received communication strategies lecture)
Number of subjects: 38
Study 28618297 — intervention group
Group type: COMPARATOR
Intervention: Untrained group (no communication strategies lecture)
Number of subjects: 38
Study 26703661 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention with health coach-facilitated virtual visits and cloud-based glucose monitoring system
Number of subjects: 10
Study 26703661 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 10
Study 23508600 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching
Number of subjects: 299
Study 23508600 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 299
Study 21393097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (AEP scores available to physician)
Number of subjects: 102
Study 21393097 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 102
Study 21393097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (QOLIE-31 scores)
Number of subjects: 102
Study 21393097 — intervention group
Group type: COMPARATOR
Intervention: Control group (QOLIE-31 scores)
Number of subjects: 102
Study 18178063 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic load diet (25% energy from protein, 45% from low glycemic index carbohydrates)
Number of subjects: 31
Study 18178063 — intervention group
Group type: COMPARATOR
Intervention: Control diet (carbohydrate-dense foods without reference to glycemic index)
Number of subjects: 31
Study 18178063 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic load diet
Number of subjects: 31
Study 16829707 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg once daily)
Number of subjects: 26
Study 16829707 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 mg once daily)
Number of subjects: 26
Study 12809582 — intervention group
Group type: EXPERIMENTAL
Intervention: isoniazid for six months (6H)
Number of subjects: 319
Study 12809582 — intervention group
Group type: EXPERIMENTAL
Intervention: rifampin plus isoniazid for three months (3RH)
Number of subjects: 319
Study 12809582 — intervention group
Group type: EXPERIMENTAL
Intervention: rifampin plus pyrazinamide for two months (2RZ)
Number of subjects: 319
Study 12809582 — intervention group
Group type: COMPARATOR
Intervention: no treatment (NT)
Number of subjects: 319
Study 10819341 — intervention group
Group type: EXPERIMENTAL
Intervention: H. influenzae type b capsular polysaccharide‐tetanus protein conjugate vaccine
Number of subjects: 174